+
1.
How does the treatment effect size of attention bias modification (ABM) compare with those observed in randomized controlled trials with anxious adults such as cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs)?
2.
This study added a neutral-neutral training condition to test whether change in attention bias from different training conditions may influence the treatment outcome. What previous findings prompted this addition?
3.
Anxiety-reducing effects of ABM could arise from increases in general attentional control regardless of emotional valence. How can future studies test this issue?